GLAXOSMITHKLINE AND PHARMACOPEIA ENTER INTO DRUG DISCOVERY AND DEVELOPMENT ALLIANCE

Pharmacopeia, an innovator in the discovery and development of novel small molecule therapeutics, and GlaxoSmithKline, a leading global pharmaceutical company, today announced the formation of a new drug discovery and development alliance. GSK, through its recently established Center of Excellence for External Drug Discovery (CEEDD), and Pharmacopeia will collaborate to deliver clinically validated therapeutic candidates to GSK's global research and development organization.

PR Newswire (http://www.prnewswire.com/cgi-bin/stories.pl?ACCT=104&STORY=/www/story/03-30-2006/0004329802&EDATE=)